PerkinElmer
PKI
#1279
Rank
NZ$24.56 B
Marketcap
$195.85
Share price
-0.91%
Change (1 day)
-23.17%
Change (1 year)
PerkinElmer, Inc. is an American chemical and medical technology company with operations in environmental health and human health.

P/E ratio for PerkinElmer (PKI)

P/E ratio on July 18, 2023 (TTM): 15.0

According to PerkinElmer 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 14.9666. At the end of 2022 the company had a P/E ratio of 30.6.

P/E ratio history for PerkinElmer from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202230.623.53%
202124.712.14%
202022.1-53.43%
201947.429.9%
201836.532.99%
201727.412.59%
201624.3-14.11%
201528.3-9.01%
201431.210.5%
201328.2-44.74%
201251.0

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
34.5 130.83%๐Ÿ‡บ๐Ÿ‡ธ USA
34.0 127.08%๐Ÿ‡บ๐Ÿ‡ธ USA
36.4 143.50%๐Ÿ‡บ๐Ÿ‡ธ USA
26.9 79.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-59.2-495.72%๐Ÿ‡บ๐Ÿ‡ธ USA
40.1 168.25%๐Ÿ‡บ๐Ÿ‡ธ USA
-5.45-136.45%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.